Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NEVANAC 3MG/ML COLIRIO EN SUSPENSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/NEVANAC 3MG/ML COLIRIO EN SUSPENSION

Approved

STANDARD

NEVANAC 3MG/ML COLIRIO EN SUSPENSION

Novartis Europharm Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Sep 21, 2023
Approval ID: f94d68aea015f54d
Company: Novartis Europharm Limited
Type: Standard

Approval Details

Approval Id: f94d68aea015f54d
Drug Cima Aemps Name: NEVANAC 3MG/ML COLIRIO EN SUSPENSION
Register Number: 107433003IP
Holder Company Name: Novartis Europharm Limited
Marketing Company Name: Difarmed S.L.
Holder Company Detail Path: /organization/novartis-europharm-limited
Authorization Date: 2023-09-21
Dosage Form: COLIRIO EN SUSPENSIÓN
Dose: 3 mg/ml
Route Of Administration: VÍA OFTÁLMICA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Novartis Europharm Limited
Company Detail Path: /organization/novartis-europharm-limited

Company Information

Pharmaceutical Company Name: NOVARTIS EUROPHARM LIMITED
Country Name: United Kingdom
City Name: camberley,country_gb
Address: 200 Frimley Business Park

Active Ingredients

NEPAFENACO

3,0 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 21, 2023

Approval ID

f94d68aea015f54d

Type

Standard

Back to CIMA-AEMPS Approvals